Trial Profile
Open label phase II study to assess induction chemotherapy using cisplatin and vinorelbine (navelbine) followed by concomitant chemo-irradiation for unresectable non-metastatic non-small cell lung cancer (Protocol PLY-DY0001)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2005
Price :
$35
*
At a glance
- Drugs Antineoplastics (Primary) ; Cisplatin (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms DYLAN
- 01 Aug 2005 New trial record.